|
Dedicated to Lifelong Learning |
![]() |
| Purpose...Current
Drug Therapy is a regular feature of the Journal, intended to update
internists on new medications, new uses of older drugs, and current issues
and controversies in pharmacology. The articles should focus on the clinical
issues relevant to an internist's daily practice and be concise and easily
understood by a generalist.
Style...We are striving to make the Journal an important part of continuing medical education for internists. Therefore the style of the article should be similar to that of a CME presentation, using a minimum of jargon and highlighting key points and new developments that the internist can quickly incorporate into his or her practice. Format...About six Journal pages including tables, figures and references (12 to 15 doubled-spaced, typed pages). Content...The article should discuss the pharmacokinetics of the drug at a level appropriate for a generalist, but focus on issues of the medication's use, contraindications, and common and uncommon side effects. Specific issues of cost, dosage, and alternative medications should also be discussed. However, Current Drug Therapy can also be used to discuss general pharmacologic issues, such as the growing problem of antibiotic resistance. The article should be moderately referenced. We encourage using treatment algorithms to assist the physician in prescribing the drug and monitoring the patient. For more information: Please do not hesitate to contact either the section editor, Dr. Donald G.Vidt or the CCJM managing editor, Phillip E. Canuto for additional information:
|
|
CCJM Home | Current Issue | Past Issues | Supplements Instructions for Authors | Subscriptions | AdvertisingRates | CME Department
|
|||